(Q50554156)

15 March 2018

title

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy. (English)

1 reference

15 March 2018

1

P Ljungman

1 reference

15 March 2018

A Locasciulli

2

1 reference

15 March 2018

V G de Soria

3

1 reference

15 March 2018

A N Békássy

4

1 reference

15 March 2018

L Brinch

5

1 reference

15 March 2018

I Espigado

6

1 reference

15 March 2018

A Ferrant

7

1 reference

15 March 2018

I M Franklin

8

1 reference

15 March 2018

J O'Riordan

9

1 reference

15 March 2018

M Rovira

10

1 reference

15 March 2018

P Shaw

11

1 reference

15 March 2018

H Einsele

12

1 reference

15 March 2018

Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

13

1 reference

15 March 2018

language of work or name

English

0 references

publication date

12 December 2011

1 reference

15 March 2018

Bone Marrow Transplantation

published in

1 reference

15 March 2018

volume

47

1 reference

15 March 2018

issue

9

1 reference

15 March 2018

page(s)

1217-1221

1 reference

15 March 2018

Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Hepatitis C virus in long-term bone marrow transplant survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Disease progression and the risk factor analysis for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

The epidemiology of hepatitis C infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Long-term outcome of hepatitis C infection after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.238

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/BMT.2011.238

1 reference

15 March 2018

1 reference

15 March 2018